For further information, please email jdp@cianalysis.com or call one of our offices:

East Coast US OfficeNew Jersey, U.S.+1 973 347 7750

West Coast US OfficeSan Francisco, U.S.+1 415 889 0392

European OfficeLondon, UK+44 20 8832 7900

Indian OfficeNew Delhi, India+91 11 40 66 00 60

Chinese OfficeBeijing, China+86 10 65 62 93 95

Empowering Healthcare through Evidence Based Solutions

Partnering with the Life Science industry in the provision of evidence based solutions. We optimize clients’ product and corporate development strategies, maximizing their return on investment opportunities. Our solutions are based on intelligence gathering and industry expertise combining to create actionable insight and recommendations.

Mission Statement

Expe

rtis

eM

issi

onPr

acti

ces

EBS

Providing greater levels of insight within a fast changing healthcare environmentThe availability of competitor and market insight is increasingly important in today’s market. Organizations, divisions and brands with access to timely and relevant ‘evidence’ are able to make quicker, more informed decisions. Partnering with CIS Life Sciences provides a competitive advantage.

In-depth, targeted and timely intelligence providing the supporting evidence required

Global executive profile offering high levels of scientific, commercial and industry expertise

Putting the findings into context as they relate to the competitor, market and client

Providing evidence based solutions designed to meet specific client needs

SDA

HSI

Empowering Healthcare through Evidence Based Solutions

Evid

ence

Expe

rtis

eCo

ntex

tSo

luti

ons

03.EBSEvidence Based SolutionsStrategic fact based consultancy in core areas of drug development, LCM and BD

Secondary Data AnalyticsCost effective analysis of publically available intelligence

Human Source InsightIn-depth primary intelligence

gathering & analysis

01.SDA

02.HSI

Customized Solutions Platform through the seamless collaboration of three separate practices

The three practices can be commissioned independently or relevant skill sets from two or more combined to offer a tailored approach to meet individual client needs.

Customized Solutions Platform

Empowering Healthcare through Evidence Based Solutions

Expe

rtis

eM

issi

onPr

acti

ces

EBS

SDA

HSI

Evid

ence

Expe

rtis

eCo

ntex

tSo

luti

ons

Insightful analysis of publically available dataSecondary Data Analytics (SDA) employs the necessary clinical and commercial expertise to source and analyze clinical trial databases, other publically available databases, peer-review publications, analyst reports, congress/conference proceedings, news feeds, company filings etc. The data are analyzed and implications for the disease area and client are provided.

Cost effective platform combined with a proactive client management approachIn response to client demand, we have combined a competitively priced secondary analytics platform with a proactive face-to-face client management approach. The integrated structure of our Indian, Chinese, U.S. and European offices enables us to deliver cost effective executive ready deliverables supported by in person consultation where necessary.

01. Secondary Data Analytics

Empowering Healthcare through Evidence Based Solutions

Expe

rtis

eM

issi

onPr

acti

ces

EBS

SDA

HSI

Clinical Trial Tracking and Analysis:

Keeping abreast of competitor clinical

trial activity & results within distinct

indications, in combination with contextual

analysis of implications to the competitor

and the client

Competitive Landscape:

Tracking products in clinical development

by indication, phase and modality,

with concurrent analyzed timeline and

milestone scenarios, including filing and

launch projections

Competitor Pipelines:

Evaluation of organizations development

pipelines and product portfolios through

the analysis of distinct therapy area

franchises and projected development/

growth scenarios

Key Opinion Leaders:

Mapping and analyzing KOL affiliations and

opinions by disease area and geography

Equity Analysts:

Understanding the views of the investment

community through a monthly synopsis of

analyst reports, calls and presentations

by disease area, product, topic or

organization

Synthesizing and interpreting publically available secondary information SDA assesses day-to-day competitor and market activities. Offerings include:

Evid

ence

Expe

rtis

eCo

ntex

tSo

luti

ons

Medical Meeting Coverage:

Collation and analysis of publically

available information at medical meetings

focusing on drug specific clinical data and

development plans plus the positioning and

messaging of selected organizations

Media Monitoring:

Compilation of a daily or weekly news-

letter providing an analyzed synopsis of

relevant news from major open source and

subscription outlets

02. Human Source Insight

Providing greater insight through ethical human source elicitation

Human Source Insight (HSI) provides competitive & business insight based on the marriage of primary intelligence, disease area expertise and industry experience. Adding primary intelligence to that reported in the public domain enables HSI to gain greater insight into the activities and strategies of selected organizations and dynamics of specified markets.

Getting answers that Market Research & Secondary Information can not As recognized experts in ethical primary elicitation, coupled with extensive experience of the Life Sciences, we are able to conduct peer-to-peer level conversations with key respondents and perform in-depth analysis of findings. HSI can answer questions on or gain insight into organizational and market issues which would otherwise remain unanswered by MR or secondary information.

Empowering Healthcare through Evidence Based Solutions

Manufacturing Analysis:

Analyzing organizations’ manufacturing

capabilities at a product/technology level

focusing on supply chains, capacities

and cost structures

Medical Meetings:

Gathering human source intelligence

at medical meetings through intensive

expert primary elicitation focusing on

specific indications, organizations and

products

Disease Areas: Monitoring activity and assessing im-

plications within a specific disease area

focusing on landscapes, timelines and

developmental, pre-launch, launch and

LCM strategies

Corporate Profiling:

Understanding the structure, activity and

strategies of organizations at a corporate,

business unit, franchise, product or

process level

Business Development & Licensing:

Supporting business development

initiatives through target and technology

identification, NPV modelling, M&A

due diligence and Emerging Market

assessment

Market Entry:

Evaluating the attractiveness of a market

at a geographical or product level and

the formulation of potential entrance

strategy scenarios

Gaming:

Formulating or critiquing strategies through

competitive simulation and strategy games

tailored to the specific clinical/commercial

objectives of the franchise or brand team

Tactical Intelligence:

Obtaining immediate answers to specific

questions through a retainer-based

service

Expe

rtis

eM

issi

onPr

acti

ces

EBS

SDA

HSI

A portfolio of flexible, customized offeringsOur offerings portfolio covers a broad spectrum of service from quick turnaround pieces of ‘Tactical Intelligence’ to twelve month disease area ‘Tracker Programs’.Ev

iden

ceEx

pert

ise

Cont

ext

Solu

tion

s

03. Evidence Based Solutions

Strategic and tactical advice based on the marriage of expertise and evidence

Evidence Based Solutions (EBS) offers a refreshing change to regular consultancy in that all of our recommendations are supported by current and validated evidence. We provide a niche service, operating in the space between intelligence agencies and strategic management consultancies.

We work closely with our clients helping to formulate new and modify existing strategies through offering an impartial perspective based on tangible evidence and relevant expertise. EBS employs experts in various fields including preclinical and clinical development, the major disease areas, drug marketing, LCM, generics & biosimilars, and emerging markets. We are equally strong in both traditional pharmaceuticals and biologics.

Empowering Healthcare through Evidence Based Solutions

Pre-Clinical:

Helping to maximize efficiencies in

preclinical development to expedite IND

timelines and due diligence on potential

preclinical licensing opportunities

Clinical Development: Optimizing clinical development to

expedite time to filing, enhancing

competitive positioning and evaluation of

business development opportunities

Product Marketing:

Enhancing competitive positioning and

maximizing messaging and differentiation

opportunities

Lifecycle Management:

Developing novel strategies to extend

product revenue streams

Biosimilars & Generics:

Preparing for and defending against

generic & biosimilar competition and

assessing opportunities in the sector

Expe

rtis

eM

issi

onPr

acti

ces

EBS

SDA

HSI

Empowering your decisions and maximizing the ROI of your strategies

EBS executives are engaged by clients to help clarify their thinking in a number of areas including:

Evid

ence

Expe

rtis

eCo

ntex

tSo

luti

ons

Emerging Markets Identification and assessment of potential

business and outsourcing opportunities

in Emerging Markets

Empowering Healthcare through Evidence Based Solutions

Drug Development & Marketing

Pre-clinical development

Clinical development

Pre-launch and launch

Market access & reimbursement

Sales & Marketing

LCM

Generics & Biosimilars

Expe

rtis

eM

issi

onPr

acti

ces

EBS

SDA

HSI

An Expert and Innovative Executive TeamFormed in 1995, CIS Life Sciences has a multi disciplinary executive team (MSc/MBA/PhD/MD level) based out of our offices in New Jersey, San Francisco, London, New Delhi and Beijing. Our expertise includes:

Evid

ence

Expe

rtis

eCo

ntex

tSo

luti

ons

Oncology & Hematology Immunology & Inflammatory Diseases CardiologyMetabolic DiseasesCNSInfectious DiseasesGastroenterologyOphthalmologyBone Disease UrologyDermatology Women’s Health

A Large and Diverse Client Base

Our client base comprises leading organizations from the following areas:

Pharmaceuticals & Biopharmaceuticals

Biotechnology

Speciality Pharma

Generics

Medical Devices

Diagnostics

CROs & CMOs

OTC Pharmaceuticals

Animal Healthcare

Private Equity & Banks

The key contact within the client organization varies from Competitive & Business Intelligence Managers, the Brand Team, R&D, Business Development, Emerging Markets and other corporate functions.

Business Functions

Business Development & Licensing

Manufacturing Analysis

Emerging Markets

Our therapeutic area expertise includes: